Shah and Wang Share Insights Into Optimized CAR T-Cell Therapy in Hematologic Malignancies

Dr. Shah and Dr. Wang discuss the management of cytokine release syndrome and neurotoxicity, the referral process, and the need for academic and community collaboration for CAR T-cell therapy in hematologic malignancies.